P
317.25
19.51 (6.55%)
| 前收盘价格 | 297.74 |
| 收盘价格 | 299.07 |
| 成交量 | 558,479 |
| 平均成交量 (3个月) | 907,524 |
| 市值 | 8,800,163,840 |
| 价格/销量 (P/S) | 842.93 |
| 股市价格/股市净资产 (P/B) | 24.04 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2025 |
| 营业利益率 (TTM) | -2,868.84% |
| 稀释每股收益 (EPS TTM) | -10.66 |
| 季度收入增长率 (YOY) | 1,349.10% |
| 总债务/股东权益 (D/E MRQ) | 0.24% |
| 流动比率 (MRQ) | 8.44 |
| 营业现金流 (OCF TTM) | -163.91 M |
| 杠杆自由现金流 (LFCF TTM) | -90.04 M |
| 资产报酬率 (ROA TTM) | -39.95% |
| 股东权益报酬率 (ROE TTM) | -63.56% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Praxis Precision Medicines, Inc | 看跌 | 看涨 |
AIStockmoo 评分
-1.4
| 分析师共识 | -0.5 |
| 内部交易活动 | -1.0 |
| 价格波动 | -5.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -1.40 |
|
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.16% |
| 机构持股比例 | 122.02% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 843.00 (BTIG, 165.72%) | 购买 |
| 中 | 450.00 (41.84%) | |
| 低 | 95.00 (Wedbush, -70.06%) | 卖出 |
| 平均值 | 489.56 (54.31%) | |
| 总计 | 8 购买, 1 卖出 | |
| 平均价格@调整类型 | 272.99 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 12 Jan 2026 | 95.00 (-70.06%) | 卖出 | 275.74 |
| 05 Dec 2025 | 83.00 (-73.84%) | 卖出 | 247.99 | |
| BTIG | 29 Dec 2025 | 843.00 (165.72%) | 购买 | 304.58 |
| 08 Dec 2025 | 507.00 (59.81%) | 购买 | 270.98 | |
| Oppenheimer | 15 Dec 2025 | 750.00 (136.41%) | 购买 | 276.40 |
| Guggenheim | 09 Dec 2025 | 760.00 (139.56%) | 购买 | 258.13 |
| Jefferies | 09 Dec 2025 | 450.00 (41.84%) | 购买 | 258.13 |
| HC Wainwright & Co. | 08 Dec 2025 | 340.00 (7.17%) | 购买 | 270.98 |
| 05 Dec 2025 | 340.00 (7.17%) | 购买 | 247.99 | |
| Needham | 08 Dec 2025 | 315.00 (-0.71%) | 购买 | 270.98 |
| 05 Dec 2025 | 304.00 (-4.18%) | 购买 | 247.99 | |
| TD Cowen | 08 Dec 2025 | 353.00 (11.27%) | 购买 | 270.98 |
| Truist Securities | 08 Dec 2025 | 500.00 (57.60%) | 购买 | 270.98 |
| 显示更多 | ||||
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| KELLY TIMOTHY EDWIN | 294.38 | 285.61 | 6,383 | 1,904,765 |
| MASTROCOLA LAUREN | 294.38 | 285.61 | 3,004 | 892,967 |
| NEMIROFF ALEX | 294.38 | 285.61 | 5,101 | 1,521,541 |
| SNIECINSKI MEGAN | 294.38 | 282.10 | 7,653 | 2,275,832 |
| SOUZA MARCIO | 294.38 | 290.54 | 22,983 | 6,791,659 |
| 累积净数量 | 45,124 | |||
| 累积净值 ($) | 13,386,765 | |||
| 累积平均购买 ($) | 294.38 | |||
| 累积平均卖出 ($) | 285.83 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| KELLY TIMOTHY EDWIN | 职员 | 12 Jan 2026 | 处理 (-) | 943 | 275.74 | 260,023 |
| NEMIROFF ALEX | 职员 | 12 Jan 2026 | 处理 (-) | 768 | 275.74 | 211,768 |
| SNIECINSKI MEGAN | 职员 | 12 Jan 2026 | 处理 (-) | 885 | 275.74 | 244,030 |
| MASTROCOLA LAUREN | 职员 | 12 Jan 2026 | 处理 (-) | 344 | 275.74 | 94,855 |
| SOUZA MARCIO | 职员 | 10 Jan 2026 | 处理 (-) | 4,252 | 288.45 | 1,226,489 |
| KELLY TIMOTHY EDWIN | 职员 | 10 Jan 2026 | 处理 (-) | 1,335 | 288.45 | 385,081 |
| NEMIROFF ALEX | 职员 | 10 Jan 2026 | 处理 (-) | 917 | 288.45 | 264,509 |
| SNIECINSKI MEGAN | 职员 | 10 Jan 2026 | 处理 (-) | 1,087 | 288.45 | 313,545 |
| MASTROCOLA LAUREN | 职员 | 10 Jan 2026 | 处理 (-) | 367 | 288.45 | 105,861 |
| SOUZA MARCIO | 职员 | 08 Jan 2026 | 获得 (+) | 27,640 | 294.38 | 8,136,663 |
| KELLY TIMOTHY EDWIN | 职员 | 08 Jan 2026 | 获得 (+) | 8,800 | 294.38 | 2,590,544 |
| NEMIROFF ALEX | 职员 | 08 Jan 2026 | 获得 (+) | 6,875 | 294.38 | 2,023,863 |
| SNIECINSKI MEGAN | 职员 | 08 Jan 2026 | 获得 (+) | 9,625 | 294.38 | 2,833,408 |
| MASTROCOLA LAUREN | 职员 | 08 Jan 2026 | 获得 (+) | 3,750 | 294.38 | 1,103,925 |
| SOUZA MARCIO | 职员 | 07 Jan 2026 | 处理 (-) | 405 | 292.63 | 118,515 |
| KELLY TIMOTHY EDWIN | 职员 | 07 Jan 2026 | 处理 (-) | 139 | 292.63 | 40,676 |
| NEMIROFF ALEX | 职员 | 07 Jan 2026 | 处理 (-) | 89 | 292.63 | 26,044 |
| MASTROCOLA LAUREN | 职员 | 07 Jan 2026 | 处理 (-) | 35 | 292.63 | 10,242 |
| 显示更多 | ||||||
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合